AAREY DRUGS & PHARM LTD (AAREYDRUGS) financials

AAREY DRUGS & PHARM LTD (AAREYDRUGS) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 1990, Aarey Drugs & Pharmaceuticals Ltd is a manufacturer of API / Bulk Drugs and offers products for diverseindustrial applications[1]

Market Cap: ₹356Cr.
Current Price: ₹110
Stock P/E: 85.3
ROE: 2.75%
ROCE: 5.58%
Book Value: ₹53.0
Dividend Yield: 0.00%
52W High / Low: ₹119/50.3

In Jun 2026, AAREY DRUGS & PHARM LTD (AAREYDRUGS) reported sales ₹44.63 Cr and net profit ₹1.02 Cr.

Annual TTM: sales ₹415 Cr, net profit ₹4 Cr.

Shareholding: Promoters 41.46% (Sep 2026), FIIs 4.28% (Sep 2026), DIIs 1.44% (Sep 2026), Public 52.83% (Sep 2026), No. of Shareholders 13,485% (Sep 2026).

AAREYDRUGS quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	105.14	133.79	108.10	102.21	84.16	96.43	189.47	44.63
Expenses	101.42	131.59	112.31	100.50	81.52	97.94	185.13	43.31
Operating Profit	3.72	2.20	-4.21	1.71	2.64	-1.51	4.34	1.32
OPM %	3.54%	1.64%	-3.89%	1.67%	3.14%	-1.57%	2.29%	2.96%
Other Income	0.02	0.68	7.54	1.55	0.79	4.18	-0.43	1.72
Interest	0.49	0.58	1.30	1.04	1.26	0.92	1.78	1.67
Depreciation	1.51	0.90	0.41	0.49	0.69	0.83	0.85	0.85
Profit before tax	1.74	1.40	1.62	1.73	1.48	0.92	1.28	0.52
Tax %	8.62%	48.57%	71.60%	20.81%	31.08%	38.04%	-21.88%	-98.08%
Net Profit	1.60	0.72	0.47	1.37	1.02	0.57	1.56	1.02
EPS in Rs	0.57	0.25	0.17	0.48	0.36	0.20	0.55	0.36
Raw PDF	—	—	—	—	—	—	—	—

AAREYDRUGS profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	298	348	493	419	396	474	472	415
Expenses	294	344	481	411	391	471	465	408
Operating Profit	3	5	11	8	4	3	7	7
OPM %	1.1%	1.3%	2.3%	1.8%	1.1%	0.6%	1.5%	1.6%
Other Income	7	7	3	3	7	10	6	6
Interest	2	2	2	3	4	5	5	6
Depreciation	1	1	2	2	2	2	3	3
Profit before tax	7	8	10	6	5	6	5	4
Tax %	20%	21%	35%	37%	12%	34%	27%	—
Net Profit	6	7	7	4	5	4	4	4
EPS in Rs	2.48	2.78	2.58	1.49	1.67	1.42	1.40	1.47
Dividend Payout %	-0%	-0%	-0%	-0%	-0%	-0%	-0%	—

AAREYDRUGS balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	23	23	23	25	25	28	28	28
Reserves	63	69	75	88	92	105	110	122
Borrowings	16	18	18	14	38	31	35	50
Other Liabilities	43	84	116	117	136	139	117	97
Total Liabilities	146	194	233	245	291	303	291	297
Fixed Assets	12	12	14	14	14	13	16	18
CWIP	-0	-0	-0	-0	-0	-0	-0	8
Investments	0	0	0	0	0	1	2	2
Other Assets	133	181	218	230	277	289	272	269
Total Assets	146	194	233	245	291	303	291	297

AAREYDRUGS cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	1	3	5	0	-1	-3	10	10
Cash from Investing Activity	-1	-1	-3	-3	0	-2	-6	-12
Cash from Financing Activity	-2	-2	-2	2	1	6	-4	2
Net Cash Flow	-3	0	0	-0	1	1	-0	-0
Free Cash Flow	-1	2	3	-2	-2	-4	5	-2
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	37%	135%	154%	36%	13%	-37%	421%	164%

AAREYDRUGS shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	44.80%	44.80%	44.80%	44.80%	39.05%	37.71%	37.71%	41.46%
FIIs	2.34%	2.34%	1.97%	1.13%	3.86%	4.18%	4.81%	4.28%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	1.62%	1.62%	1.44%
Public	52.86%	52.86%	53.23%	54.07%	57.09%	56.49%	55.87%	52.83%
No. of Shareholders	16,288	16,257	15,796	14,897	14,063	14,188	13,478	13,485

AAREYDRUGS key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	109	118	170	101	165	170	103	100
Inventory Days	23	21	20	11	26	33	36	33
Days Payable	40	98	120	86	115	123	81	66
Cash Conversion Cycle	92	42	69	26	76	80	58	68
Working Capital Days	77	99	91	68	89	106	89	90
ROCE %	12%	8%	9%	10%	6%	6%	6%	6%

AAREYDRUGSUpdated 22 Oct 2026, 23:27

Aarey Drugs & Pharm Ltd

AAREYDRUGSUpdated 22 Oct 2026, 23:27

Market Cap

₹356Cr.

Current Price

₹110

High / Low

₹119/50.3

Stock P/E

85.3

Book Value₹53.0

Dividend Yield0.00%

ROCE5.58%

ROE2.75%

Face Value₹10.0

About

Incorporated in 1990, Aarey Drugs & Pharmaceuticals Ltd is a manufacturer of API / Bulk Drugs and offers products for diverseindustrial applications[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	50.96	0.42	49.62	0.7	0.89	0.73	0	0.72	0.28
Sep 2023	57.83	0.41	55.99	0.84	1.27	1	-22	1.23	0.48
Dec 2023	76.48	0.47	73.78	0.29	1.06	1.46	30.14	1.02	0.4
Mar 2024	210.35	0.4	211.79	5.14	1.15	2.15	-0.47	2.15	0.77
Jun 2024	126.91	0.96	125.73	1.58	0.47	1.33	6.77	1.24	0.44
Sep 2024	105.14	0.49	101.42	0.02	1.51	1.74	8.62	1.6	0.57
Dec 2024	133.79	0.58	131.59	0.68	0.9	1.4	48.57	0.72	0.25
Mar 2025	108.1	1.3	112.31	7.54	0.41	1.62	71.6	0.47	0.17
Jun 2025	102.21	1.04	100.5	1.55	0.49	1.73	20.81	1.37	0.48
Sep 2025	84.16	1.26	81.52	0.79	0.69	1.48	31.08	1.02	0.36
Dec 2025	96.43	0.92	97.94	4.18	0.83	0.92	38.04	0.57	0.2
Mar 2026	189.47	1.78	185.13	-0.43	0.85	1.28	-21.88	1.56	0.55
Jun 2026	44.63	1.67	43.31	1.72	0.85	0.52	-98.08	1.02	0.36

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	213	1	212	3	1	1	23	1	0.65
Mar 2016	246	2	245	3	1	2	29	1	0.77
Mar 2017	396	4	386	3	1	8	31	5	3.02
Mar 2018	349	2	342	3	1	8	25	6	2.64
Mar 2019	354	2	347	4	1	9	27	7	2.8
Mar 2020	298	2	294	7	1	7	20	6	2.48
Mar 2021	348	2	344	7	1	8	21	7	2.78
Mar 2022	493	2	481	3	2	10	35	7	2.58
Mar 2023	419	3	411	3	2	6	37	4	1.49
Mar 2024	396	4	391	7	2	5	12	5	1.67
Mar 2025	474	5	471	10	2	6	34	4	1.42
Mar 2026	472	5	465	6	3	5	27	4	1.4
TTM	415	6	408	6	3	4	—	4	1.47

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	41.46%
FIIs	4.28%
DIIs	1.44%
Public	52.83%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	50.04%	3.83%	0%	46.12%
Mar 2024	45.28%	3.4%	0%	51.31%
Jun 2024	45.28%	3.4%	0%	51.32%
Sep 2024	45.44%	2.75%	0%	51.81%
Dec 2024	44.8%	2.34%	0%	52.86%
Mar 2025	44.8%	2.34%	0%	52.86%
Jun 2025	44.8%	1.97%	0%	53.23%
Sep 2025	44.8%	1.13%	0%	54.07%
Dec 2025	39.05%	3.86%	0%	57.09%
Mar 2026	37.71%	4.18%	1.62%	56.49%
Jun 2026	37.71%	4.81%	1.62%	55.87%
Sep 2026	41.46%	4.28%	1.44%	52.83%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	17	19	11	69	115	6	0	0	109	115
Mar 2016	17	20	15	74	125	8	0	0	117	125
Mar 2017	18	31	10	83	142	12	0	0	130	142
Mar 2018	23	57	3	86	170	12	0	0	157	170
Mar 2019	23	63	16	43	146	12	0	0	133	146
Mar 2020	23	69	18	84	194	12	0	0	181	194
Mar 2021	23	75	18	116	233	14	0	0	218	233
Mar 2022	25	88	14	117	245	14	0	0	230	245
Mar 2023	25	92	38	136	291	14	0	0	277	291
Mar 2024	28	105	31	139	303	13	0	1	289	303
Mar 2025	28	110	35	117	291	16	0	2	272	291
Mar 2026	28	122	50	97	297	18	8	2	269	297

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	3	-2	-2	-1
Mar 2016	6	-3	-2	1
Mar 2017	1	-5	4	-1
Mar 2018	-20	-1	23	2
Mar 2019	1	-1	-2	-3
Mar 2020	3	-1	-2	0
Mar 2021	5	-3	-2	0
Mar 2022	0	-3	2	0
Mar 2023	-1	0	1	1
Mar 2024	-3	-2	6	1
Mar 2025	10	-6	-4	0
Mar 2026	10	-12	2	0

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	114	108	75	100	109	118	170	101	165	170	103	100
Inventory Days	7	3	5	16	23	21	20	11	26	33	36	33
Days Payable	117	108	71	84	40	98	120	86	115	123	81	66
Cash Conversion Cycle	5	3	9	32	92	42	69	26	76	80	58	68
Working Capital Days	49	40	34	69	77	99	91	68	89	106	89	90
ROCE %	7%	7%	22%	14%	12%	8%	9%	10%	6%	6%	6%	6%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of AAREY DRUGS & PHARM LTD (AAREYDRUGS)?

The reported market capitalisation for AAREY DRUGS & PHARM LTD (AAREYDRUGS) is ₹356Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of AAREYDRUGS?

The current price shown for AAREY DRUGS & PHARM LTD (AAREYDRUGS) on Fincrux is ₹110 with a 52-week high/low of ₹119/50.3.

What is the P/E ratio of AAREY DRUGS & PHARM LTD (AAREYDRUGS)?

The stock P/E for AAREY DRUGS & PHARM LTD (AAREYDRUGS) is 85.3 on Fincrux, with ROE at 2.75% and ROCE at 5.58%.

What were AAREYDRUGS latest quarterly results?

For Jun 2026, AAREY DRUGS & PHARM LTD (AAREYDRUGS) reported sales ₹44.63 Cr and net profit ₹1.02 Cr (figures in ₹ crore unless noted).

What are AAREYDRUGS annual sales and net profit?

For TTM, AAREY DRUGS & PHARM LTD (AAREYDRUGS) shows sales of ₹415 Cr and net profit of ₹4 Cr on the Fincrux profit & loss statement.

Who owns AAREY DRUGS & PHARM LTD (AAREYDRUGS)?

Latest shareholding for AAREY DRUGS & PHARM LTD (AAREYDRUGS) on Fincrux: Promoters 41.46% (Sep 2026), FIIs 4.28% (Sep 2026), DIIs 1.44% (Sep 2026), Public 52.83% (Sep 2026), No. of Shareholders 13,485% (Sep 2026).

Where can I find AAREY DRUGS & PHARM LTD (AAREYDRUGS) financials?

AAREY DRUGS & PHARM LTD (AAREYDRUGS) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show AAREYDRUGS balance sheet and cash flow?

Yes. The AAREY DRUGS & PHARM LTD (AAREYDRUGS) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 22 October 2026 at 23:27